Clinical Trials Directory

Trials / Completed

CompletedNCT05414643

Management of Acute Cardiogenic Shock at the New Brunswick Heart Centre

Status
Completed
Phase
Study type
Observational
Enrollment
1,416 (actual)
Sponsor
New Brunswick Heart Centre · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

In Atlantic Canada, acute myocardial infarction occurs at a rate of 2.9 % of the population and is the most common cause of cardiogenic shock (CS). In many studies, acute myocardial infarction accounts for up to 80% of the patients with CS. While there are different methods of treating patients with CS, the rate of mortality has not significantly improved over the years and remains as high as 50%. Recent studies have shown that a multi-modal, team-based approach can help improve patient outcomes; however, such a standardized approach is yet to be implemented in the New Brunswick Heart Centre (NBHC). The study aims to understand the difference in outcomes between two groups of patients treated for CS: SHOCK TEAM versus non-SHOCK TEAM. This is a retrospective study of 168 patients using the data from NBHC registry and patient charts. The study duration is 1 year. The primary outcome is hospital survival. Secondary outcomes include time from diagnosis to invasive monitoring and intervention. All data will be analyzed statistically between the two groups. The end goal of the study is to establish standard guidelines to treat CS patients and improve patient survival.

Conditions

Interventions

TypeNameDescription
OTHERStandard careNo interventions were used, as this is an observational study.

Timeline

Start date
2021-01-14
Primary completion
2021-10-13
Completion
2021-10-13
First posted
2022-06-10
Last updated
2022-06-10

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05414643. Inclusion in this directory is not an endorsement.